Long intergenic non-protein coding RNA 1834 (LINC01834)

Long intergenic non-protein coding RNA 1834 (LINC01834) is a long non-coding RNA (lncRNA), specifically a member of the long intergenic non-coding RNA (lincRNA) family, which are RNA transcripts longer than 200 nucleotides transcribed from genomic regions that do not overlap protein-coding genes[1][3][7]. LincRNAs are implicated in a variety of nuclear and cytoplasmic functions, including remodeling chromatin, regulating transcription, stabilizing RNA transcripts, and more broadly influencing the expression of neighboring or functionally related genes through diverse mechanisms[3][7]. LINC01834 itself has been annotated in the human genome, but as of current evidence, there is a lack of published, experimentally validated data specifically describing its biological role, disease association, or clinical relevance[1]. Generally, lincRNAs as a class increasingly show relevance as regulators in cancer and other disease contexts, often acting through epigenetic modulation, chromatin remodeling, and as molecular scaffolds or sponges for regulatory RNAs or proteins[3][7]. However, no such functional characterization has yet been ascribed specifically to LINC01834. Notes: - This entry is *not* considered a classical drug target (e.g., receptor, enzyme, transporter, etc.), as there is no literature supporting direct therapeutic intervention or targeting of LINC01834[1]. - There are no known drugs or experimental molecules interacting with LINC01834, nor is it reported as a biomarker or safety concern in the literature to date[1]. - If you require information about lincRNAs as a broad class, rather than LINC01834 specifically, refer to sources detailing lincRNA biology and classification[3][7]. - The entry is valid and correctly spelled, but **lacks specific functional and disease role characterization as of current databases and literature**[1].

Other names

LINC01834long intergenic non-coding RNA 1834